Activated CD8+ T cells can recognize the expressed neoepitope–HLA complexes on tumor cells and then kill cancer cells through the degranulation of cytotoxic proteins, such as perforin, granzyme, and granulysin. This evidence concerns the gene CD8A and neoplasm.